AB 1906 adds qualifying cervical screening home test coverage
Oct 4, 2026 edition · GC-2026-0249 · Published 2026-10-04 · Version 2 · Final
AB 1906 addresses 2027 cervical screening and self-collection coverage, with commercial scope and conditional Medi-Cal requirements.
What happened
California approved and filed AB 1906 on September 27. Affected commercial contracts and policies issued, amended or renewed on or after January 1, 2027 must cover cervical cancer screening ordered or provided by an in-network provider acting within scope and consistent with the referenced screening recommendations. The covered tests include Pap tests, FDA-approved HPV screening and FDA-authorized or cleared self-collected cervical screening kits usable outside a clinical setting. The text prohibits cost sharing for covered services under the section, subject to preservation of HSA-eligible high-deductible status. Specified specialized, vision-only, dental-only and Medicare supplement products are excluded; the commercial plan section excludes Medi-Cal managed care.
The separate Medi-Cal provisions address screening and authorized or cleared home kits on or after January 1, 2027, subject to medical necessity, utilization management and federal-law limits. Kits must be ordered or provided by the patient’s provider consistently with the screening recommendations and Medi-Cal policy, with clinically appropriate CPT or HCPCS billing. The kit provisions apply to fee-for-service and managed care, protect beneficiaries from cost sharing including share of cost or spend down, and depend on necessary federal approvals and available federal participation that is not jeopardized. DHCS may issue implementation instructions. As of October 4, neither the commercial contract date nor device authorization alone establishes readiness of every Medi-Cal payment pathway.
Scope and timing
- Authority status
- Final
- Applicability
- Potentially applicable
- Audience
- Health systems, Provider networks, Health-tech
- Jurisdiction
- California
- Affected functions
- Managed Care, Compliance, Clinical Operations
- Responsible owner
- Managed Care
- Recorded date
- 2027-01-01
- Date type
- implementation
Why it matters
Access depends on approved test type, provider order, product scope and billing setup; commercial and Medi-Cal pathways have different conditions.
Recommended action
Prepare affected 2027 commercial benefits and HSA treatment, verify test authorization and provider requirements, and track Medi-Cal approvals, coding and DHCS guidance before activating claims changes.
Implementation playbook
- Confirm affected members, benefits and contracts against the final statutory scope. Managed Care · Due 2026-10-18
- Confirm order, network and kit requirements and benefit edits; track separate Medi-Cal implementation guidance. Compliance · Due 2027-01-01
- Validate updated workflows, communicate changes and monitor implementing guidance. Compliance · Due 2027-01-01
Sources
- AB1906 enacted final textOfficial · California Legislature · 2026-09-27 · Source review 2026-10-05
Complete edition and supplemental material
This finding in the complete approved report →Regulatory horizons, CIA trends and implementation trackers remain in the full report.
Read the entire Medicare & Medicaid report →